Indonesia allows Taiwan's COVID-19 vaccine candidate to conduct clinical trial
09/13/2021 12:05 PM
Taiwanese vaccine producer Adimmune Corp. said on Monday that it has gained approval from the Indonesian government to conduct Phase 2 clinical trials for its COVID-19 vaccine candidate, with results expected to be released next year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwanese shuttler Lin Chun-yi finishes 2nd at Orléans Masters
03/10/2025 10:49 AM - Society
High of 30°C forecast for parts of Taiwan Monday
03/10/2025 10:19 AM - Business
U.S. dollar up in Taipei trading
03/10/2025 10:11 AM - Society
Taiwan headline news
03/10/2025 10:09 AM - Business
Taiwan shares open lower
03/10/2025 09:11 AM